MEGHAN KINTER: Open Payments
NPI 1043702772 · MARYSVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 82 payments from 20 companies in 2025. Trend: 2023 $1,495 · 2024 $1,833 · 2025 $1,364
Food & beverage: $1,364
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $232 |
| Amgen Inc. | 14 | $155 |
| ABBVIE INC. | 12 | $150 |
| Novo Nordisk Inc | 10 | $146 |
| Lilly USA, LLC | 9 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Vanda Pharmaceuticals Inc. | 2 | $70 |
| Biogen, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 3 | $49 |
Products named: FARXIGA, Wegovy, BREZTRI, VRAYLAR, OTEZLA, XIFAXAN, REXULTI, MOUNJARO.
Industry payments across MI — which companies pay providers there.
